GREEN ANDREW M 4
Research Summary
AI-generated summary
Artivion (AORT) SVP Andrew M. Green Exercises Options, Sells Shares
What Happened
Andrew M. Green, Senior Vice President, Regulatory and Quality at Artivion, exercised stock options totaling 44,001 shares on June 11, 2026 and then sold those shares in open-market transactions the same day. He paid $589,078 to exercise the options (14,001 shares @ $18.44 = $258,178; 30,000 shares @ $11.03 = $330,900) and received gross proceeds of about $910,739 from the sales (14,001 shares sold at a weighted average $20.71 = $289,919; 30,000 shares sold at a weighted average $20.69 = $620,820). The Form 4 also shows two derivative "Disposed" entries at $0.00 for 14,001 and 30,000 shares associated with the exercises.
Key Details
- Transaction date: June 11, 2026 (filed June 15, 2026). Filing was 4 days after the trades (may be later than the typical two-business-day Form 4 deadline).
- Exercises: 14,001 @ $18.44 ($258,178) and 30,000 @ $11.03 ($330,900).
- Sales: 14,001 sold at weighted avg $20.71 ($289,919; range $20.25–$21.02 per footnote F2), 30,000 sold at weighted avg $20.69 ($620,820; range $20.24–$21.02 per footnote F3). Total sale proceeds ≈ $910,739.
- Additional entries: Two derivative disposals at $0.00 for 14,001 and 30,000 shares (reported alongside the exercises).
- Plan/vesting notes: Transactions were executed under a Rule 10b5-1 trading plan adopted March 12, 2026 (F1). Option grants vest 33 1/3% per year (first exercisable dates noted in F4 and F5).
- Shares owned after transaction: Not reported in the provided filing.
Context
- This was an exercise-and-sell (options exercised and resulting shares sold the same day), commonly used to realize gains or cover exercise costs/taxes. The presence of a 10b5-1 plan indicates the sales were prearranged.
- Sales by executives are common and do not by themselves indicate company performance; purchases generally carry more direct bullish signal for retail investors.